Abstracts

CD4+ T-CELL SUBSET-SPECIFIC DIFFERENCES IN HIV LATENCY ESTABLISHMENT

CD4 T cells are primary targets of HIV infection and contribute to life-long latency. Single-cell analysis of HIV latency is hampered by the difficulties identifying cells with transcriptionally silent proviruses. To better support multi-dimensional analyses, we used a HIV reporter virus, pLAI2-?E-Pro-Codes, to identify CD4 T cell subsets most prone to harboring LTR-silent provirus. To…

GLUTAMINOLYSIS ALTERS CD4+ T-CELL IMMUNOMETABOLISM AND INHIBITS HIV TRANSCRIPTION

We recently reported (Giron et al., Nature Comm. 2021) that the plasma levels of the metabolite glutamic acid predict a delayed time-to-viral-rebound and a higher probability of achieving a post-treatment controller phenotype after antiretroviral therapy (ART) interruption. Glutamic acid metabolism (glutaminolysis) can fuel the tricarboxylic acid (TCA) cycle through its conversion to ?-ketoglutarate (?-KG), which…

HIV LATENCY REVERSAL VIA IAP ANTAGONISM AND TARGETED BET BROMODOMAIN INHIBITION

Accelerating reservoir decay through reversal of HIV latency and clearance of infected cells may facilitate an HIV cure. Recent preclinical studies have demonstrated that non-canonical NF-?B agonists (IAP antagonists, IAPi) induce unprecedented levels of proviral expression without toxicity during suppressive ART in two animal models of latent SIV/HIV infection. However, combination approaches may be needed…

SMYD5 ACTIVATES HIV-1 TRANSCRIPTION AND IS UPREGULATED BY Tat AND USP11

Despite great efforts, ‘shock and kill’ approaches have so far failed to significantly reduce the size and impact of latent HIV-1 reservoirs. There is a need to develop alternative, possibly complementary, strategies to ‘shock and kill’ to achieve durable viral control in the absence of antiretroviral therapy (ART). Transcriptional silencing in latency research is a…

PREDICTING COVID-19 CLINICAL PROTECTIVE IMMUNITY FROM SARS-CoV-2 T-CELL RESPONSES

SARS-CoV-2 produces variable immune responses leading to different levels of immune protection. The relationship between neutralizing antibody level (NAb) and protective immunity has been well characterized after infection and vaccination. While comparatively specific T cell responses tend to be more variable, the impacts of these responses have broad implications on long-term immunity and their role…

NATURAL KILLER CELL-MEDIATED ADCC IN SARS-CoV-2 INFECTION AND VACCINATION

COVID-19, caused by SARS-CoV-2, has emerged as a global pandemic. While immune responses of the adaptive immune system have been in the focus of research, the role of Natural killer (NK) cells in COVID-19 remains poorly understood. We characterized NK cell-mediated SARS-CoV-2 antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 spike-1 (S1) and nucleocapsid (NC) protein using…

DIVERGENT ADAPTIVE IMMUNE RESPONSES DEFINE 2 TYPES OF LONG COVID

More than 10% of patients infected with SARS-CoV-2 experience a Long COVID syndrome, characterized by the persistence of a diverse array of symptoms where fatigue predominates. The role of the adaptive immune response in Long COVID remains poorly understood, with contrasting hypotheses suggesting either an insufficient antiviral response or an excessive immune response that would…